ZAI LAB LTD's ticker is ZLAB and the CUSIP is 98887Q104. A total of 223 filers reported holding ZAI LAB LTD in Q3 2021. The put-call ratio across all filers is 1.79 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,671 | -54.4% | 151 | -47.9% | 0.00% | – |
| Q2 2023 | $8,042 | – | 290 | +2800.0% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 10 | -95.7% | 0.00% | – |
| Q1 2022 | $10,000 | -95.4% | 230 | -93.4% | 0.00% | – |
| Q4 2021 | $217,000 | -7.7% | 3,460 | +55.0% | 0.00% | – |
| Q3 2021 | $235,000 | -39.1% | 2,232 | +2.3% | 0.00% | -100.0% |
| Q2 2021 | $386,000 | +31.3% | 2,182 | -0.7% | 0.00% | 0.0% |
| Q1 2021 | $294,000 | +6.5% | 2,198 | +7.9% | 0.00% | 0.0% |
| Q4 2020 | $276,000 | +94.4% | 2,037 | +18.8% | 0.00% | – |
| Q3 2020 | $142,000 | +111.9% | 1,714 | +111.9% | 0.00% | – |
| Q2 2020 | $67,000 | +252.6% | 809 | +118.1% | 0.00% | – |
| Q1 2020 | $19,000 | +111.1% | 371 | +68.6% | 0.00% | – |
| Q4 2019 | $9,000 | +125.0% | 220 | +59.4% | 0.00% | – |
| Q3 2019 | $4,000 | -20.0% | 138 | 0.0% | 0.00% | – |
| Q2 2019 | $5,000 | +25.0% | 138 | 0.0% | 0.00% | – |
| Q1 2019 | $4,000 | +33.3% | 138 | 0.0% | 0.00% | – |
| Q4 2018 | $3,000 | – | 138 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Genesis Investment Management, LLP | 1,032,166 | $25,091,955 | 3.50% |
| XY Capital Ltd | 139,743 | $3,397,152 | 1.95% |
| Paradigm Biocapital Advisors LP | 1,142,383 | $27,771,331 | 1.88% |
| Privium Fund Management B.V. | 240,683 | $5,851,004 | 1.74% |
| Segantii Capital Management Ltd | 1,788,999 | $43,262,801 | 1.52% |
| Vivo Capital, LLC | 454,606 | $11,051,472 | 1.21% |
| BRILLIANCE ASSET MANAGEMENT LTD | 157,085 | $3,818,736 | 0.96% |
| Capricorn Fund Managers Ltd | 100,967 | $2,454,508 | 0.85% |
| Rock Springs Capital Management LP | 1,237,023 | $30,072,029 | 0.81% |
| Long Corridor Asset Management Ltd | 31,000 | $753,610 | 0.66% |